Gerard Ian Evan FRS, FMedSci (born 17 August 1955) is a British biologist and, since May 2022, Professor of Cancer Biology at King's College London and a principal group leader in the Francis Crick Institute. Prior to this he was Sir William Dunn Professor of Biochemistry and Head of Biochemistry at the University of Cambridge (2009-2022).[11][13]
Gerard Evan
| |
---|---|
Born | (1955-08-17) 17 August 1955 (age 68)[10] |
Alma mater | St Peter's College, Oxford King's College, Cambridge[10] |
Known for | Disease Models & Mechanisms |
Awards | Fellow of the Royal Society (2004) FMedSci (1999)[1] PhD (1982) |
Scientific career | |
Fields | Cancer[2][3][4][5][6][7] Disease biology Myc regulator gene[8] p53 tumour suppressor[9] |
Institutions | University of Oxford University of Cambridge UCSF[10][11] Cancer Research UK[12] Ensemble Therapeutics |
Thesis | Monoclonal antibodies as reagents for the analysis of cell surfaces (1982) |
Website | www labmed |
Evan was educated at St Peter's College, Oxford, where he studied Biochemistry, and King's College, Cambridge, where he was awarded his PhD in 1982 for research using Monoclonal antibodies.[10][14]
Evan does research to the determine the molecular basis of cancer.[15][16][17][18][19][20][21][22]
Prior to Cambridge, Evan was Royal Society Napier Professor at University College London and the Imperial Cancer Research Fund (1988-99), then Gerson & Barbara Bass Bakar Distinguished Professor of Cancer Biology, at University of California, San Francisco (1999-2011).
Academic offices | ||
---|---|---|
Preceded by [[]] |
Professor of Cancer BiologyatKing's College London 2020–present |
Incumbent |